Susan Buchbinder | Academic Influence

Susan Buchbinder's AcademicInfluence.com Rankings

Susan Buchbinder

Philosophy

#7334

World Rank

#10530

Historical Rank

#1619

USA Rank

Logic

#4393

World Rank

#5677

Historical Rank

#792

USA Rank

philosophy Degrees

Download Badge

Philosophy

Susan Buchbinder's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Susan Buchbinder Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Susan Buchbinder is an American physician who is best known for her work in HIV prevention and as a researcher in the HIV Vaccine Trials Network. In 2011, she was elected a fellow of the American Association for the Advancement of Science. She is Clinical Professor of Medicine, Epidemiology and Biostatistics at the University of California, San Francisco.

(See a Problem?)

Susan Buchbinder's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. (2010) (3668)
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene (1996) (2691)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial (2008) (1743)
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. (1999) (1317)
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS (2002) (1231)
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. (2014) (970)
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. (1997) (963)
Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men (2012) (797)
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) (1998) (761)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis (2008) (750)
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 (2007) (746)
Risk factors for HIV infection among men who have sex with men (2006) (696)
Per-contact risk of human immunodeficiency virus transmission between male sexual partners. (1999) (678)
Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities (2009) (558)
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. (2013) (536)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel (2018) (527)
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. (2001) (520)
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. (2016) (514)
Genetic acceleration of AIDS progression by a promoter variant of CCR5. (1998) (483)
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial (2008) (441)
Long‐term HIV‐1 infection without immunologic progression (1994) (417)
Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection (1999) (405)
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. (1996) (360)
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. (1996) (359)
Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. (2004) (353)
Influence of HLA-C Expression Level on HIV Control (2013) (343)
High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. (2003) (343)
What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)? (2012) (331)
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. (2000) (314)
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine (2021) (308)
Herpes zoster and human immunodeficiency virus infection. (1992) (304)
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. (1999) (284)
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C (2009) (283)
Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data (2001) (282)
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity (2001) (269)
Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men (2005) (267)
Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. (2004) (265)
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. (1991) (261)
The prevalence of oral lesions in HIV‐infected homosexual and bisexual men: three San Francisco epidemiological cohorts (1991) (259)
Sexual Risk, Nitrite Inhalant Use, and Lack of Circumcision Associated With HIV Seroconversion in Men Who Have Sex With Men in the United States (2005) (258)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. (2011) (257)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. (2020) (246)
Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco (2014) (244)
Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. (1990) (240)
New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. (2005) (235)
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis (2005) (230)
Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial (2011) (229)
No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis (2013) (228)
The Circuit Party Men's Health Survey: findings and implications for gay and bisexual men. (2001) (226)
Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. (2005) (221)
Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion (2002) (219)
APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS (2004) (208)
Modulating influence on HIV/AIDS by interacting RANTES gene variants (2002) (202)
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). (2012) (200)
Elite control of HIV infection: implications for vaccines (2006) (194)
Drug Use and Sexual Risk Behavior Among Gay and Bisexual Men Who Attend Circuit Parties: A Venue‐Based Comparison (2001) (189)
Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061 (2013) (189)
KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections (2006) (188)
‘Barebacking’ in a diverse sample of men who have sex with men (2002) (183)
Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. (1991) (182)
Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation (2004) (181)
Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. (1998) (180)
HIV infection (2015) (180)
High Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection: Baseline Data From the US PrEP Demonstration Project (2015) (176)
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study (2017) (171)
Concomitant Socioeconomic, Behavioral, and Biological Factors Associated with the Disproportionate HIV Infection Burden among Black Men Who Have Sex with Men in 6 U.S. Cities (2014) (163)
Limited Knowledge and Use of HIV Post- and Pre-Exposure Prophylaxis Among Gay and Bisexual Men (2008) (161)
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine (2010) (159)
Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States (2013) (158)
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy (2017) (157)
Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men (2009) (155)
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. (2001) (153)
Increased incidence of Hodgkin disease in homosexual men with HIV infection. (1992) (151)
Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco (2011) (150)
Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial (2014) (147)
Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men (2006) (146)
Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes (2016) (144)
Readiness of high‐risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States (1998) (143)
Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type. (2004) (142)
Progression to AIDS in HIV‐infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis (1992) (141)
Sexual Risk Behavior Among HIV-Uninfected Men Who Have Sex With Men Participating in a Tenofovir Preexposure Prophylaxis Randomized Trial in the United States (2013) (140)
Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load (2015) (140)
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. (2015) (136)
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. (2012) (134)
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. (2001) (133)
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls (2013) (133)
Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. (1996) (131)
HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. (2014) (125)
Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP) (2014) (124)
Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. (1999) (123)
Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. (2006) (121)
Association of DC-SIGN Promoter Polymorphism with Increased Risk for Parenteral, but Not Mucosal, Acquisition of Human Immunodeficiency Virus Type 1 Infection (2004) (120)
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells (2018) (119)
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. (2001) (116)
Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial (2007) (115)
Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection (2006) (112)
Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men (2012) (110)
The association between cigarette smoking and selected HIV‐related medical conditions (1996) (108)
Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif (2001) (107)
Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. (2001) (106)
Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts (1994) (105)
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. (2010) (104)
Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. (2002) (103)
HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World's First HIV Vaccine Efficacy Trial (2005) (103)
HIV incidence determination in the United States: a multiassay approach. (2013) (102)
Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection (2003) (102)
Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. (1994) (101)
Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. (1996) (101)
Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. (1994) (99)
Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. (2017) (93)
Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. (2010) (91)
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. (1999) (90)
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. (1996) (90)
HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. (1990) (90)
Correlates of condom failure in a sexually active cohort of men who have sex with men. (1999) (89)
Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study (2016) (88)
Serosorting Is Associated with a Decreased Risk of HIV Seroconversion in the EXPLORE Study Cohort (2010) (84)
Hepatitis C virus infection in sexually active homosexual men. (1994) (83)
Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. (2010) (82)
Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. (1999) (82)
Infrequent HIV Testing and Late HIV Diagnosis Are Common Among a Cohort of Black Men Who Have Sex With Men in 6 US Cities (2014) (82)
Motivations for Participating in an HIV Vaccine Efficacy Trial (2005) (81)
Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results (2000) (81)
Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. (2001) (81)
MCP-1-MCP-3–Eotaxin gene cluster influences HIV-1 transmission (2003) (80)
Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. (2006) (79)
Serum β2-microglobulin and prediction of progression to AIDS in HIV infection (1992) (78)
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. (1999) (78)
Promote HIV Chemoprophylaxis Research, Don't Prevent It (2005) (77)
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2014) (77)
Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, san francisco, 1981–1989 (1991) (77)
Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. (1997) (77)
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study (2018) (76)
HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial (2014) (76)
Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. (2001) (76)
Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. (2013) (75)
Combination antiretroviral therapy and incidence of AIDS-related malignancies. (1999) (75)
Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States (2013) (74)
Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study) (2011) (74)
Regulatory Polymorphisms in the Cyclophilin A Gene, PPIA, Accelerate Progression to AIDS (2007) (74)
Immune Activation with HIV Vaccines (2014) (73)
HERPES SIMPLEX VIRUS TYPE 2 INFECTION AS A RISK FACTOR FOR HUMAN IMMUNODEFICIENCY VIRUS ACQUISITION IN MEN WHO HAVE SEX WITH MEN (2002) (73)
Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. (2006) (73)
A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing (2014) (73)
Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes (2004) (72)
Age, Race/Ethnicity, and Behavioral Risk Factors Associated With Per Contact Risk of HIV Infection Among Men Who Have Sex With Men in the United States (2014) (69)
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition (1997) (68)
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. (1999) (68)
Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches (2011) (67)
Depression and use of mental health services among HIV-infected men. (1996) (66)
Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA Alleles (2001) (65)
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. (2006) (65)
APOBEC3B deletion and risk of HIV-1 acquisition. (2009) (65)
T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant (1996) (65)
Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil (2016) (64)
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. (2016) (63)
High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. (2006) (63)
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection (2014) (61)
Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals (2007) (61)
Genome-wide association study implicates PARD3B-based AIDS restriction. (2011) (60)
Rectal Microbicides for U.S. Gay Men: Are Clinical Trials Needed? Are They Feasible? (1998) (59)
Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. (2014) (59)
Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. (1998) (58)
Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study (2014) (58)
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial (2017) (57)
HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications. (1999) (57)
HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. (2002) (56)
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. (1997) (56)
A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis (2018) (56)
CD40 ligand and IFN‐γ synergistically restore IL‐12 production in HIV‐infected patients (1998) (55)
Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences (1999) (55)
The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. (1995) (55)
Negotiated Safety Relationships and Sexual Behavior Among a Diverse Sample of HIV-Negative Men Who Have Sex With Men (2005) (55)
Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities (2015) (55)
Economic, Legal, and Social Hardships Associated with HIV Risk among Black Men who have Sex with Men in Six US Cities (2016) (54)
Male circumcision and risk of HIV acquisition among MSM (2011) (52)
HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. (1994) (51)
Genetic Variants in Nuclear-Encoded Mitochondrial Genes Influence AIDS Progression (2010) (50)
Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation (2000) (50)
Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates. (1992) (49)
Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic (2014) (48)
Use of adenovirus type-5 vectored vaccines: a cautionary tale (2020) (46)
Degree of Housing Instability Shows Independent “Dose-Response” With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus (2018) (44)
Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine (2018) (43)
Acceptability of self-conducted home-based HIV testing among men who have sex with men in Brazil: data from an on-line survey. (2014) (42)
Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. (2016) (42)
Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection (2011) (42)
Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial (2019) (41)
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders (2015) (40)
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens (2011) (40)
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen (2017) (40)
Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network (2019) (40)
HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1 (2013) (39)
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV (2021) (39)
Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses Which Can Be Defined to the Epitope Level (2008) (38)
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. (2004) (37)
Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas. (2008) (37)
Persistence of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Clones in a Subject with Rapid Disease Progression (2001) (36)
Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. (1999) (36)
The HVTN Protocol 903 Vaccine Preparedness Study: Lessons Learned in Preparation for HIV Vaccine Efficacy Trials (2008) (35)
A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation (2014) (35)
Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the “Getting to Zero” Era (2018) (35)
Missed opportunities to prevent HIV infections among pre‐exposure prophylaxis users: a population‐based mixed methods study, San Francisco, United States (2020) (35)
HLA tapasin independence: broader peptide repertoire and HIV control (2020) (34)
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. (2014) (34)
The complex challenges of HIV vaccine development require renewed and expanded global commitment (2019) (34)
Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). (2000) (34)
Negative Social Impacts Among Volunteers in an HIV Vaccine Efficacy Trial (2007) (34)
Use of reality "female condoms" for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team. (1999) (33)
Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 (2006) (33)
Targeting Pre-Exposure Prophylaxis Among Men Who Have Sex With Men in the United States and Peru: Partnership Types, Contact Rates, and Sexual Role (2015) (32)
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell–mediated control of HIV-1, HCV, and HTLV-1 (2018) (32)
Anal Sex Role Segregation and Versatility Among Men Who Have Sex With Men: EXPLORE Study (2013) (32)
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. (1998) (31)
Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele1 (2004) (31)
Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. (2010) (31)
Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. (1993) (31)
The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection. (1994) (31)
A factorial survey study to assess the acceptability of HIV vaccine trial designs. (1996) (31)
Understanding PrEP Persistence: Provider and Patient Perspectives (2020) (31)
Insurance type and satisfaction with medical care among HIV-infected men. (1997) (30)
Maximizing the Benefits of HIV Preexposure Prophylaxis. (2018) (30)
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project (2017) (29)
Sexual Risk Behaviors, Circumcision Status, and Preexisting Immunity to Adenovirus Type 5 Among Men Who Have Sex With Men Participating in a Randomized HIV-1 Vaccine Efficacy Trial: Step Study (2012) (29)
Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics. (2019) (28)
Integrated Strategies for Combination HIV Prevention: Principles and Examples for Men Who Have Sex With Men in the Americas and Heterosexual African Populations (2013) (28)
Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. (1999) (28)
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial (2018) (28)
Beliefs About HIV Reinfection (Superinfection) and Sexual Behavior Among a Diverse Sample of HIV-Positive Men Who Have Sex With Men (2004) (28)
Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System (2018) (27)
Getting to Zero San Francisco: A Collective Impact Approach. (2019) (27)
Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. (2012) (26)
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (2017) (26)
Body weight and oral contraceptives are the most important modulators of serum CRP levels (2008) (25)
Sexual Frequency and Planning Among At-Risk Men Who Have Sex With Men in the United States: Implications for Event-Based Intermittent Pre-Exposure Prophylaxis (2012) (25)
The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. (1991) (25)
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials (2015) (25)
Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network (2018) (25)
Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil (2018) (25)
Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials. (1994) (25)
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study (2020) (25)
Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia (2016) (25)
PrEP Persistence is a Critical Issue in PrEP Implementation. (2020) (24)
Can Male Circumcision Have an Impact on the HIV Epidemic in Men Who Have Sex with Men? (2014) (24)
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis (2017) (24)
Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination (2012) (24)
HIV Diversity as a Biomarker for HIV Incidence Estimation: Including a High-Resolution Melting Diversity Assay in a Multiassay Algorithm (2013) (24)
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. (2016) (23)
Client and Provider Perspectives on New HIV Prevention Tools for MSM in the Americas (2015) (23)
Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia (2011) (23)
DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men (2020) (22)
CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. (1998) (22)
Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a U.S. City. (2019) (22)
HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil (2017) (22)
Cofactors for HIV Disease Progression in a Cohort of Homosexual and Bisexual Men (2001) (22)
Communication of HIV viral load to guide sexual risk decisions with serodiscordant partners among San Francisco men who have sex with men (2006) (21)
Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project (2019) (20)
Slow Diffusion of Home HIV-Specimen Collection: Provider Concerns at Odds With Client Preferences (2001) (20)
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial (2019) (20)
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study (2005) (20)
CROI 2019: advances in HIV prevention and plans to end the epidemic. (2019) (19)
Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs. (2014) (19)
In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities. (2013) (19)
Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United States (2015) (19)
Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials. (2012) (18)
Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression (2003) (18)
Lessons Drawn From Recent HIV Vaccine Efficacy Trials (2010) (17)
Periodontal disease in HIV-infected and uninfected homosexual and bisexual men. (1992) (17)
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial (2018) (17)
Over-the-counter human immunodeficiency virus self-test kits: time to explore their use for men who have sex with men in Brazil (2014) (16)
Early versus deferred antiretroviral therapy for HIV. (2009) (16)
HIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with men. (2020) (16)
The −1030/−862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia (2003) (15)
Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection (2017) (15)
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. (2016) (14)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. (2022) (14)
Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition (2013) (14)
Health insurance and use of medical services by men infected with HIV. (1995) (14)
Declines in AIDS Incidence Associated with Highly Active Anti-Retroviral Therapy (HAART) Are Not Reflected in KS and Lymphoma Incidence. (1998) (14)
HIV epidemiology and breakthroughs in prevention 30 years into the AIDS epidemic. (2011) (14)
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. (2019) (13)
Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials. (1996) (13)
What is the potential impact of adult circumcision on the HIV epidemic among men who have sex with men in San Francisco? (2010) (13)
Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. (2007) (13)
Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic (2015) (13)
Partner-Specific Sexual Behavioral Differences Between Phase 3 HIV Vaccine Efficacy Trial Participants and Controls: Project VISION (2006) (12)
Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition. (2014) (12)
CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention. (2016) (12)
Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition (2015) (12)
The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes. (2007) (12)
Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort (2019) (12)
Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities (1993) (11)
Aceptabilidad del examen de VIH autoadministrado en casa con hombres que practican sexo con hombres en Brasil: datos de una encuesta por internet (2014) (11)
Low-Level Viremia Early in HIV Infection (2014) (11)
Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. (1992) (11)
CROI 2015: Advances in HIV Testing and Prevention Strategies. (2015) (11)
The epidemiology of new HIV infections and interventions to limit HIV transmission. (2009) (11)
CROI 2018: Epidemic Trends and Advances in HIV Prevention. (2018) (10)
Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States (2019) (10)
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis. (2020) (10)
Erratum: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10 (Proceedings of the National Academy of Sciences of the United States of America (2000) 97:26 (14467-14472)) (2001) (10)
Rectal use of nonoxynol-9 among men who have sex with men (2003) (9)
Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial. (2014) (9)
Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. (2020) (9)
SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV (2021) (8)
HIV epidemiology, testing strategies, and prevention interventions. (2010) (8)
Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men. (1994) (8)
LILRB 2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection (2014) (8)
Correction: What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)? (2013) (8)
Hair as a biological marker of daily oral pre-exposure prophylaxis (PrEP) adherence and tenofovir/emtricitabine (TFV/FTC) exposure in the global iPrEx study (2011) (7)
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project. (2019) (7)
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature (2020) (7)
Eff ect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men : a randomised , double-blind , placebo-controlled trial (2008) (7)
The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants (2014) (6)
CROI 2014: New tools to track the epidemic and prevent HIV infections. (2014) (6)
Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States. (2015) (6)
CROI 2017: HIV Epidemic Trends and Advances in Prevention. (2017) (6)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection (2016) (5)
Ending AIDS in the United States-If Not Now, When? (2019) (5)
Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations. (2000) (5)
Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men (2021) (5)
Faculty Opinions recommendation of Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. (2007) (5)
Predictors of HIV disease progression in the era of prophylactic therapies. (1992) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
HIV epidemiology and prevention interventions. (2007) (5)
Long-term Human Immunodeficiency Virus (HIV) Infection Without Immunologic Progression (1994) (4)
Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy. (2008) (4)
Sources of racial/ethnic differences in awareness of HIV vaccine trials. (2014) (4)
Note: High interest in doxycycline for sexually transmitted infection post-exposure prophylaxis (doxycycline-PEP) in a multi-city survey of men who have sex with men (MSM) using a social-networking app. (2019) (4)
High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application. (2019) (4)
Short-Term Adherence Marker to PrEP Predicts Future Non-Retention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. (2019) (4)
Long-Term Non-Progressive HIV Infection (2000) (3)
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. (2023) (3)
A novel missense mutation T101N in the melanocortin-4 receptor gene associated with obesity. (2011) (3)
Impact of Insurance Type on Receipt of Medical Care by HIV-Infected Men (1996) (3)
Avoiding infection after HIV exposure. (1998) (3)
Deletion and Risk of HIV-1 Acquisition (2009) (3)
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors (2019) (3)
Sexual frequency and planning among at-risk MSM in the US: Implications for daily vs. intermittent pre-exposure prophylaxis (PrEP) (2011) (3)
Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women (2011) (3)
Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. (2021) (3)
Sensitivity and Specificity of the National Death Index for Multiple Causes of Death in People With HIV (2021) (3)
STIs: an unintended consequence of improved sexual health? (2019) (2)
HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights (2019) (2)
Erratum: Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition (AIDS (2013) 27 (1763-1770)) (2013) (2)
Maturity-Onset Diabetes of the Young (MODY) caused by a novel nonsense mutation E41X in the HNF-1α gene. (2010) (2)
Antiretroviral use for prevention and other factors affecting the course of the HIV-1 epidemic. (2012) (2)
The importance of PrEP persistence in preventing HIV infections on PrEP (2020) (2)
HIV Testing and Prevention Strategies (2008) (2)
Essential for Viral Replication Escape Associated with Targeting a Sequence Nonprogressor : Constraints on Immune Recognized from a Long-Term Conserved CTL Epitope in HIV-1 p 24 Molecular and Functional Analysis of a (1999) (2)
When is good good enough for HIV-1 prophylaxis? (2014) (2)
The aspirational necessity of HIV prevention (2019) (2)
Use of Bayes theorem to estimate the impact of the proposed CD4-based expansion of the AIDS case definition. (1993) (2)
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine. (2020) (2)
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition (2021) (1)
Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination (2012) (1)
Reply to Itaya et al (2010) (1)
CROI 2013: New tools to understand transmission dynamics and prevent HIV infections. (2013) (1)
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. (2021) (1)
Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies. (2008) (1)
CROI 2021: Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research. (2021) (1)
HIVR4P 2018: From Research to Impact. (2019) (1)
Hodgkin Disease and HIV (1993) (1)
Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017). (2019) (1)
2272. High Interest in Doxycycline for Sexually Transmitted Infection Post-Exposure Prophylaxis (Doxy-PEP) in a Multi-city Survey of Men Having Sex With Men (MSM) Using a Social-Networking App (2018) (1)
Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates During Covid-19: An Interrupted Time Series Analysis (2021) (1)
mulTI-cohorT GeneTIc assocIaTIon sTudy reVeals cXcr 6 as a new chemokIne recePTor InVolVed In aIds lonG-Term non-ProGressIon (2011) (1)
Advances in Brief Reduced Risk of AIDS Lymphoma in Individuals Heterozygous for the CCR 5D 32 Mutation 1 (1999) (1)
Reply to Richie and Villasante. (2013) (1)
HIVR4P 2018: From Research to Impact Conference Summary and Highlights (2019) (1)
Consistent Effects of TSG 101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 † (2018) (1)
HIV-1 Infection in Patients with the CCR5-Δ32 Homozygous Genotype (2019) (0)
Chapter 28 AIDS epidemiology in the United States (1998) (0)
Liebensteiner of Biotic and Abiotic Reactions Archaeal ( Per ) Chlorate Reduction at High Temperature : An Interplay (2014) (0)
Erratum: Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells (Science DOI: 10.1126/science.aam8825) (2019) (0)
Adjusted relative hazards ratio of HIV seroconversion among Black MSM in HPTN 061. (2015) (0)
Hepatitis virus and HIV interactions (2014) (0)
Evaluation of serum measures of thyroid function and disease in healthy subjects with sonographically assessed thyroid gland (2004) (0)
Speci ﬁ city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi ﬁ ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles (2014) (0)
Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis (2022) (0)
HIV‐1 Infection in Individuals With the CCR5‐&dgr;32/&dgr;32 Genotype: Acquisition of Syncytium‐Inducing Virus at Seroconversion (2002) (0)
Virtual CROI 2020: Highlights of Epidemiology, Public Health, and Prevention Research. (2020) (0)
Name in bold = only the first DHAP - SE author (1997) (0)
Progress in HIV care outcomes among Black men in San Francisco. (2021) (0)
Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men (2022) (0)
Effect of Social Determinants of Health on Uncontrolled Human Immunodeficiency Virus (HIV) Infection Among Persons With HIV in San Francisco, California (2022) (0)
Epidemiology and prevention. (2006) (0)
007.5 Sexual risk behaviour and sexually transmitted diseases among men who have sex with men participating in a pre-exposure prophylaxis demonstration project (2015) (0)
Expressing the HLA-A*0201 Allele HIV-Uninfected Vaccine Recipients (SL9) Responses among Gag CTL-Positive, Absence of Immunodominant Anti-Gag p17 (2004) (0)
SourcesofRacial/EthnicDifferencesinAwareness ofHIVVaccineTrials (2014) (0)
Individual Long-Term Nonprogressing HIV-1-Infected Epitopes in HIV-1 p 17 by CTL from a Recognition of Two Overlapping CTL and (1998) (0)
International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status. (2017) (0)
Grabowski and colleagues reported data on the impact of combination HIV prevention on trends in HIV incidence in the population-based Rakai Community Cohort Study in Uganda (2017) (0)
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens (2022) (0)
Corrigendum (2019) (0)
Use a high resolution melting assay to compare and env diversity in adults with different stages of HIV infection. (2011) (0)
Faculty Opinions recommendation of Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. (2007) (0)
COVID-19 vaccination and HIV-1 acquisition – Authors’ reply (2022) (0)
HIV-1 Step Study – Authors' reply (2009) (0)
Adherence/drug detection rates and study participant experiences of counseling support among men who have sex with men (MSM) in the iPrEx pre-exposure prophylaxis (PrEP) trial in San Francisco, United States (2011) (0)
Anderson Efficacy in Men Who Have Sex with Men Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis (2012) (0)
Clinical Care Conundrums: HIV Patient Care in 2016: A Case-Based, Panel Discussion (2016) (0)
ART Advances: Long-Acting Agents in Treatment and Prevention (2018) (0)
Selected Highlights of the 2021 virtual Conference on Retroviruses and Opportunistic Infections ( Part I ) CME CROI 2021 : Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research 309 (2021) (0)
Failure of the Merck HIV vaccine: an uncertain step forward (2008) (0)
La derrota del sida y sus requisitos: Nunca es demasiado tarde (1998) (0)
Protocol Developing a Mobile App ( LYNX ) to Support Linkage to HIV / Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men : Protocol for a Randomized Controlled Trial (0)
IndividualLong-Term Nonprogressing HIV-1-Infected Epitopes in HIV-1 p17 by CTL from a Recognition of Two Overlapping CTL (1998) (0)
CROI 2022: epidemiologic trends and prevention for HIV and SARS-CoV-2. (2022) (0)
Differential immunodominance hierarchy of CD 8 + T-cell responses in HLA-B * 27 (2018) (0)
7 – Challenges in Developing HIV Vaccines (2005) (0)

This paper list is powered by the following services:

Other Resources About Susan Buchbinder

en.wikipedia.org

What Schools Are Affiliated With Susan Buchbinder?

Susan Buchbinder is affiliated with the following schools:

Image Attributions

Image Source for Susan Buchbinder